Column

Transformative Employer Trends

Shared Decision-Making on Health Care Risks

03/27/2024

This column explores the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.

This column explores the purpose...

03/27/2024

Journal of Clinical Pathways

MAI Mindset

December 2023 Pathways Impact Study Part 2: Impact of Pathway Programs on Treatment Selection

03/27/2024

Lee Blansett , MBA;

This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

This entry of our MAI Mindset...

03/27/2024

Journal of Clinical Pathways

Editor's Page

Patient-Centric Care in Precision Medicine: Overcoming Barriers, Embracing Innovation

03/27/2024

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including current trends in the utilization of biomarker testing and patient-reported outcome measures.

Editor-in-Chief Winston Wong,...

03/27/2024

Journal of Clinical Pathways

MAI Mindset

December 2023 Pathways Impact Study Part 1: Awareness and Influencers of Use

02/12/2024

Lee Blansett , MBA;

In this entry of our MAI Mindset column, Lee Blansett, MBA, summarizes a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

In this entry of our MAI Mindset...

02/12/2024

Journal of Clinical Pathways

Engaging Payers

How to Support the Adoption and Integration of Specialty Value-Based Care Models: A Conversation Across Multiple Stakeholders

02/09/2024

Lili Brillstein , MPH;

Lili Brillstein, MPH, discusses key points from the 2023 Healthcare Innovations Summit held in Aspen, Colorado, regarding the barriers to implementing value-based care models for specialty care, and what can be done to overcome them and...

Lili Brillstein, MPH, discusses...

02/09/2024

Journal of Clinical Pathways

Transformative Employer Trends

Commercial Insured Care Guideline Perspectives

02/09/2024

F. Randy Vogenberg , PhD, FASHP;

This installment of the Transformative Employer Trends column explains how organizations may seek outside consultant groups to further develop and support their care guidelines, including examples of such groups.

This installment of the...

02/09/2024

Journal of Clinical Pathways

Editor's Page

Navigating the Future of Oncology Care: Trends and Innovations for 2024

02/09/2024

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting some of the anticipated trends in health care for 2024, including a shift from a fee-for-service model to value-based care.

Editor-in-Chief Winston Wong,...

02/09/2024

Journal of Clinical Pathways

Trending From ACCC

EHR Integration: Effective Practices to Facilitate Timely and Comprehensive Biomarker Testing

02/09/2024

Association of Community Cancer Centers

This column describes key findings from the first phase of the Association of Community Cancer Centers and LUNGevity’s education program titled EHR Integrations: Effective Practices to Facilitate Timely and Comprehensive Biomarker Testing.

This column describes key...

02/09/2024

Journal of Clinical Pathways

Editor's Page

Reflecting on Growth and Impact: Clinical Pathways in Cancer Care and Beyond

12/20/2023

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the importance of reaching all patients regardless of socioeconomic status, and wishes readers well during the holiday season.

Editor-in-Chief Winston Wong,...

12/20/2023

Journal of Clinical Pathways

Trending From ACCC

Precision Medicine in Rural and Underserved Areas: Unique Solutions for Unique Challenges

12/19/2023

Rania Emara ;

Rania Emara explains the social barriers that socioeconomically affected rural groups experience with precision medicine and provides some insight into possible solutions.

Rania Emara explains the social...

12/19/2023

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products